Toll-Like Receptor 9 Agonists for Cancer Therapy
The immune system has acquired increasing importance as a key player in cancer maintenance and growth. Thus, modulating anti-tumor immune mediators has become an attractive strategy for cancer treatment. Toll-like receptors (TLRs) have gradually emerged as potential targets of newer immunotherapies....
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2014-08-01
|
| シリーズ: | Biomedicines |
| 主題: | |
| オンライン・アクセス: | http://www.mdpi.com/2227-9059/2/3/211 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
